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Abstract
Introduction: Enterobacter cloacae is responsible for 65-75% of all Enterobacter infections,
bacteremia being the most common syndrome. The majority of infections are nosocomially acquired
and in patients with predisposing factors.
Case presentation: We present a case of E. cloacae bacteremia secondary to acute cholecystitis in
a 60-year-old man with recent diagnosis of cholelithiasis. The diagnosis was established with
abdominal echography and positive blood and biliary cultures. The patient was managed successfully
with cholecystectomy and antibiotic therapy.
Conclusion: The peculiarity of our case is the development of community-acquired bacteremia due
to E. cloacae with a clear infectious focus, as a single agent isolated in several blood cultures, in a
patient without severe underlying diseases, prior antimicrobial use or previous hospital admission.
Although the majority of Enterobacter spp. infections are nosocomially acquired, primary bacteremia
being the most common syndrome, these pathogens may also be responsible for community-
acquired cases. Patients without predisposing factors may also be affected.
Introduction
Enterobacter spp. have been recognized as increasingly
important pathogens in recent years, and have been
implicated in a broad range of clinical syndromes, the
majority of which are nosocomially acquired and in
patients with predisposing factors [1]. Enterobacter cloacae
is responsible for 65-75% of all Enterobacter infections,
bacteremia being the most common syndrome [1-5].
A patient with bacteremic acute cholecystitis is presented.
Case presentation
A 60-year-old previously healthy man, with a recent
diagnosis of cholelithiasis, was admitted to our hospital
with a 24-hour history of high fever, nausea and severe
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(page number not for citation purposes)pain in the right hypochondrium. On clinical examina-
tion, mild jaundice, abdominal tenderness in the right
upper quadrant and a positive Murphy sign were noted.
His blood pressure was 110/70 mmHg, his pulse was 130
beats per minute and his temperature was 39.5ºC. He had
no leukocytosis but had significant neutrophilia, an
elevated C reactive protein level, elevated erythrocyte
sedimentation rate and elevated total bilirubin with an
elevated direct fraction. An abdominal ultrasound
revealed a relaxed gallbladder, with a thickened wall
with multiple biliary calculi and biliary mud. Empirical
treatment for acute cholecystitis was initiated with
piperacillin-tazobactam 4.5 g every 8 hours, which is one
of the options in our hospital’s protocol for the treatment
of biliary tract and gallbladder infections, mainly in very ill
patients, and patients turned down for emergency surgery.
Three days later, all sets of the blood cultures grew
E. cloacae, which was sensitive to empirical antibiotics. In
imaging techniques, such as computed tomography and
magnetic cholangioresonance, a collection was observed
in the anterior subhepatic space, suggesting an abscess.
A cholecystectomy was therefore performed, obtaining
biliary abscess exudate in which E. cloacae also grew, with
the same susceptibility as E. cloacae isolated from blood
cultures. The patient’s condition had improved after
starting antibiotic treatment, even before surgery, and no
further bacteremia was detected. Piperacillin-tazobactam
was maintained up to 4 weeks in addition to support
treatment. The patient had a favorable outcome, leaving
hospital 10 days later.
Discussion
The genus Enterobacter belongs to the family Enterobacter-
iaceae; 14 species of this genus have been described, and
E. cloacae and E. aerogenes are by far the most frequently
encountered human pathogensamong them [1]. Although
community-acquired infections with Enterobacter spp. do
occur, the majority of infections are nosocomial [1-6].
Patients at increased risk of acquiring an Enterobacter
infection include those with a prolonged hospital stay,
especially if a portion of it is spent in an intensive care unit
[1,3-5]. The incidence of bacteremia has increased
gradually accounting for nearly 11% of nosocomial
infections in some series [6,7]. The condition for devel-
opment of bacteremia due to Enterobacter spp. is severe
underlying illness, and the most commonly cited factors
associated with the acquisition of bacteremia due to
Enterobacter spp. are neoplastic disease, diabetes mellitus,
chronic renal failure, and gastrointestinal diseases [1,3-6].
Prior antimicrobial exposure, in particular, to penicillins,
has also been identified as a risk factor for this entity [6].
Compared with bacteremias due to other enteric bacilli,
Enterobacter spp. are acquired significantly more often in
hospitals, are more likely to be a component of a
polymicrobial bacteremia, and the portal of entry is
usually unknown [1-5]. When the source of infection can
be identified, the major portals of entry are the genito-
urinary and gastrointestinal tracts, followed by others such
as intravascular catheters, the respiratory tract and surgical
wounds [1,6]. The gastrointestinal tract is a common
endogenous reservoir for E. cloacae and spread of infection
from the gastrointestinal tract is difficult to ascertain,
which can explain why the portal of entry often cannot be
identified [6,7].
In our patient, bacteremia was associated with an acute
cholecystitis complicated by the development of a
subhepatic abscess that required surgery, and the same
E. cloacae was isolated in both blood and abscess exudates.
As far as we know, there has been no other reported case of
acute bacteremic cholecystitis due to E. cloacae as a single
etiologic agent.With regard to antimicrobial susceptibility,
E. cloacae is resistant to ampicillin, cefalothin and other
older cephalosporins, and cefoxitin. The carbapenems,
cefepime, aminoglycosides, and ciprofloxacin are active
against the majority of strains of E. cloacae [8-10].
Conclusion
The peculiarity of our case is the development of
community-acquired bacteremia due to E. cloacae with a
clear infectious focus, an acute cholecystitis, as a single
agent isolated in several blood cultures, in a patient
without severe underlying diseases, prior antimicrobial
use or previous hospital admission. As far as we know,
there is no other reported similar case in patients without
comorbidity.
Although the description of this case has little implication
for conventional clinical practice, as blood cultures,
antibiotherapy and surgery are usually included in cases
similar to ours, it does highlight the possibility of a
community-acquired bacteremia due to traditional noso-
comial microorganisms in patients without severe under-
lying diseases, prior antimicrobial use or previous hospital
admission.
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